Short answer: Yes, Mounjaro (tirzepatide) can cause gallstones. The UK product information lists gallstones (cholelithiasis) as a common side effect in the weight-management trials, which means up to 1 in 10 people, and an inflamed gallbladder (cholecystitis) as uncommon, up to 1 in 100 (SmPC, section 4.8). In the pooled SURMOUNT-1, -2 and -3 trials, acute gallbladder problems affected 2.0% of people on tirzepatide and 1.6% of people on placebo, and the product information links them to greater weight loss. Losing weight quickly raises the risk of gallstones whatever causes it. Whether you can take Mounjaro with gallstones depends on whether they are causing problems now: we do not supply it to anyone with gallbladder problems right now, a past history is reviewed by the pharmacist, and the product information places no restriction on people whose gallbladder has been removed.
This guide sets out what the Mounjaro and Wegovy product information, the NHS and the MHRA say about gallstones, as of November 2026: how common they are, why losing weight raises the risk, what our consultation asks, what changes after gallbladder removal, the symptoms to know and when to get urgent help.
Can Mounjaro cause gallstones?
Yes: gallstones are a listed side effect of Mounjaro, graded common in the weight-management trials, and the product information says the acute gallbladder events in those trials "were positively correlated with weight reduction". The grading is in section 4.8 of the Mounjaro KwikPen product information (text revised August 2026), which lists cholelithiasis (gallstones) as common and cholecystitis (an inflamed gallbladder) as uncommon for the weight-management trials.
The figures behind the grading, counting everyone in the pooled SURMOUNT-1, -2 and -3 weight-management trials who had the medicine or placebo, are in the table below: any acute gallbladder disease was reported in 2.0% of people on tirzepatide and 1.6% on placebo, a difference of 0.4 percentage points, and the gallstone figure itself, 1.1%, sits at the bottom of the common band. SURMOUNT-1 ran for 72 weeks in 2,539 adults with a BMI of 30 or above, or 27 or above with a weight-related condition, on 5mg, 10mg or 15mg a week.
Gallstones are also common in people who take no weight-loss medicine at all: the NHS says they affect more than 1 in 10 adults in the UK and often cause no symptoms, so many are found by chance on a scan for something else. A gallstone found during treatment is not always the medicine's doing.

Gallbladder problems and Mounjaro: what the product information says
| Event | How common | What it means for you |
|---|---|---|
| Gallstones (cholelithiasis) | Common in the weight-management trials, up to 1 in 10 people: reported by 1.1% on tirzepatide and 1.0% on placebo in SURMOUNT-1, -2 and -3 | Most gallstones cause no symptoms. Tell us about any gallstones, now or in the past, in the health questions, and tell your pharmacist if they are found during treatment |
| Inflamed gallbladder (cholecystitis) | Uncommon, up to 1 in 100 people: 0.6% against 0.2% in the same trials | A sudden, sharp pain in the upper right of your tummy that does not go away within a few hours, sometimes with a high temperature. Stop your treatment and get urgent help |
| Any acute gallbladder disease | 2.0% against 1.6% in the same trials, linked to greater weight loss | Linked to how much weight people lost. Losing weight steadily, at the usual dose steps, is the NHS advice and ours |
| Acute pancreatitis (an inflamed pancreas) | Uncommon, up to 1 in 100 people | A gallstone that blocks a duct is one cause of pancreatitis. Severe, persistent stomach pain spreading to your back needs urgent help, and Mounjaro is not restarted if pancreatitis is confirmed |
Why do weight loss injections raise the risk of gallstones?
Losing weight quickly raises the risk of gallstones whatever causes it, and the Mounjaro product information links the gallbladder problems in its trials to greater weight loss. The NHS lists having lost weight quickly, its example being weight loss surgery, among the things that make gallstones more likely, and its acute cholecystitis page explains why: low-calorie rapid weight loss diets "can disrupt your bile chemistry and actually increase your risk of developing gallstones", so it advises a more gradual weight loss plan. The product information itself gives no mechanism, and we do not add one.
The other NHS risk factors are worth knowing because many people starting treatment already have some of them: being over 40, being a woman, living with obesity, a diet high in fat and low in fibre, and a condition such as diabetes or Crohn's disease. Treatment brings weight loss, and the trials tied the gallbladder events to how much weight people lost, which is why the advice later in this guide is about the pace of it.
Can you take Mounjaro if you have gallstones?
It depends on whether your gallstones are causing problems now. Our first consultation asks about your health in two lists. One answer on the second list means we do not supply: "Gallbladder problems right now: gallstones causing pain, cholecystitis, or waiting for gallbladder surgery". Gallstones in the past, or stones found by chance that have never caused symptoms, go on the first list as "Gallbladder disease", which does not stop the consultation but marks your order for the pharmacist to review before anything is supplied. The health check before each reorder asks the second list every time, and the first list whenever you say your health has changed; a gallbladder problem answered there is flagged for your pharmacist to review before anything is sent, and if your order cannot be supplied you are refunded in full.
This is our own rule, not a restriction in the licence: the Mounjaro product information lists one contraindication, an allergy to tirzepatide or any of its other ingredients, and its warnings say nothing about gallstones. We take the stricter line because gallbladder disease that is causing symptoms needs its own treatment first, and a medicine linked to gallbladder problems, with nausea and stomach pain of its own, would muddy the picture for the doctors treating it. Waiting for gallbladder surgery is part of that answer however far off the operation is, and any operation under a general anaesthetic or deep sedation within the next 7 days stops the consultation on its own. Once your gallbladder has been treated and your surgeon or GP is happy, you can start the consultation again. If you are moving to Solira from another provider, the consultation asks the same questions; our switching page explains how a switch works.
Already a Solira patient? If you are told you have gallstones, message your pharmacist through your account before your next order. If you have the pain described below, get medical help first (the safety box at the end of this guide says when it is urgent), then let us know what you were told.
Not started treatment yet? Check whether it's suitable for you in a few minutes. A GPhC-registered pharmacist reviews every assessment, and if they can't approve your order, you get a full refund.
Check your eligibilityCan you take Mounjaro after gallbladder removal?
The UK product information places no restriction on taking Mounjaro after gallbladder removal, and our consultation does not exclude it: you tell us about the operation under "Gallbladder disease" and your pharmacist reviews it with the rest of your answers. The NHS puts it plainly: it is possible to lead a perfectly normal life without a gallbladder, because the organ stores and concentrates bile rather than making it, and your liver still produces bile to digest food.
Three practical points. Mounjaro's very common stomach effects (nausea, diarrhoea, vomiting, constipation and stomach pain) are listed for everyone, with no separate figures for people without a gallbladder, and the NHS notes that some people who have had theirs removed get bloating and diarrhoea after certain foods, so if your digestion is already sensitive, tell your pharmacist and read our guide to Mounjaro side effects before you start. If the operation was recent, your surgical team's recovery advice comes first, and an operation under a general anaesthetic in the next 7 days stops our consultation until it is over. And stones can still be left in the bile ducts after surgery, which the NHS lists among the operation's possible complications, so new pain or yellowing after the operation is for your doctor, whatever you are taking.
What are the symptoms of gallstones on Mounjaro?
Most gallstones cause no symptoms at all; the sign to know is the pain, which the NHS calls biliary colic: severe, constant, in the middle of your tummy or just under your ribs on the right, lasting longer than 30 minutes and up to several hours, and it may make you feel sick or vomit. It comes when a stone blocks a bile duct. An inflamed gallbladder (acute cholecystitis) feels different: a sudden, sharp pain in the upper right of the tummy that spreads towards the right shoulder, is tender to touch, is worse when you breathe in deeply and does not go away within a few hours, sometimes with a high temperature, sweating, feeling or being sick, loss of appetite or yellowing of the skin and the whites of the eyes.
The difficulty on Mounjaro is overlap. Nausea, vomiting and stomach pain are very common side effects, most of all in the first weeks and after each dose increase, and the MHRA has warned that the early signs of pancreatitis can be put down to those ordinary side effects. The same caution applies to the gallbladder. Ordinary Mounjaro stomach side effects are mostly mild or moderate and ease over time, and they are not a severe pain in one place that lasts for hours. A pain like that, or any pain with a fever or yellowing, is not something to wait out.
If you think it is your gallbladder
Do not wait it out. Tummy pain that lasts longer than 30 minutes needs an urgent GP appointment or a call to NHS 111, the NHS says.
Call 999 or go to A&E for sudden, severe tummy pain, pain spreading to your back with being sick, a very high temperature or feeling hot, cold or shivery, or yellow skin or whites of the eyes. Do not drive yourself: ask someone to take you or call an ambulance.
Say you take Mounjaro. Tell whoever treats you that you take tirzepatide, a GLP-1 medicine, and when your last dose was. The MHRA notes that a privately prescribed GLP-1 medicine may not be on your medical record, so nobody will know unless you say.
Then tell your pharmacist. Stop your treatment while you are being assessed, as the safety box below says, and message us from your account once you know what is happening. Do not restart until your doctor and your pharmacist agree it is safe.
How can you lower the risk of gallstones while losing weight?
Lose weight steadily rather than as fast as you can. That is the NHS advice for lowering the risk of gallstones, and it fits how Mounjaro is meant to be used: a 2.5mg starting dose for 4 weeks, then 5mg, with any further step taken after at least 4 weeks on the current dose, each one a pharmacist decision based on how you are getting on. Stomach side effects are at their highest while the dose is going up, and faster weight loss is the gallstone risk the trials point to; our guide on when to increase your Mounjaro dose explains how we decide.
Eat regularly, and keep fibre in your meals. The NHS lists a diet high in fat and low in fibre among the risk factors, and advises a healthy, balanced diet with fewer high-cholesterol foods rather than a very low-calorie plan; Mounjaro reduces appetite, so the risk is eating too little and too randomly rather than too much. Our guide on what to eat on Mounjaro has a pharmacist's practical plan. We suggest no supplement or tablet to prevent gallstones; if you have had them before, tell your GP and us.
Does Wegovy cause gallstones too?
Yes. The Wegovy product information (text revised September 2026) lists gallstones (cholelithiasis) as a common side effect, up to 1 in 10 people, and reports that in its clinical trials "cholelithiasis was reported in 1.6% and led to cholecystitis in 0.6% of patients treated with semaglutide 2.4 mg". Those were four 68-week trials in adults with a BMI of 30 or above, or 27 or above with a weight-related condition. The Wegovy table gives no separate cholecystitis grading and no placebo figure, so the two medicines' numbers are not a direct comparison. The warning signs and our rule are the same for Wegovy as for Mounjaro: we do not supply it to anyone with gallbladder problems right now, and a history of gallbladder disease is reviewed by the pharmacist. Our guides to Wegovy side effects and whether Wegovy is safe cover the rest of its safety profile, and Is Mounjaro safe? does the same for Mounjaro.
When should you get urgent help?
Stop your treatment and get urgent medical help for sudden pain in the upper right of your tummy, a fever, or yellowing of the skin or eyes, which can be signs of a gallbladder problem, and for severe, persistent stomach pain that spreads to your back, which can be a sign of pancreatitis. That is the safety advice every Solira weight-loss patient is given, word for word in the box below; the NHS thresholds for NHS 111 and 999 are in the steps above.
Pancreatitis deserves its own mention, because a gallstone is one of its causes and because the MHRA strengthened its warnings in January 2026: acute pancreatitis is an uncommon side effect of GLP-1 medicines as a class, there have been reports of severe and fatal cases, treatment is stopped if it is suspected and never restarted if it is confirmed, and we do not supply Mounjaro or Wegovy to anyone who has had pancreatitis, whether a gallstone caused it or not.

